Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 349 | 3541 | 38.3 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 721 | 12118 | COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//PULMONARY REHABILITATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | COPD | Author keyword | 169 | 17% | 26% | 926 |
| 2 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Author keyword | 139 | 14% | 25% | 896 |
| 3 | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Journal | 75 | 34% | 5% | 183 |
| 4 | EXACERBATIONS | Author keyword | 62 | 35% | 4% | 144 |
| 5 | SPIROMETRY | Author keyword | 54 | 16% | 9% | 309 |
| 6 | EXACERBATION | Author keyword | 46 | 22% | 5% | 190 |
| 7 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Journal | 43 | 27% | 4% | 134 |
| 8 | PRIMARY CARE RESPIRATORY JOURNAL | Journal | 23 | 28% | 2% | 68 |
| 9 | LOWER LIMIT OF NORMAL | Author keyword | 14 | 59% | 0% | 16 |
| 10 | PROGRAM EPIDEMIOL CLIN | Address | 14 | 64% | 0% | 14 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | COPD | 169 | 17% | 26% | 926 | Search COPD | Search COPD |
| 2 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 139 | 14% | 25% | 896 | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE |
| 3 | EXACERBATIONS | 62 | 35% | 4% | 144 | Search EXACERBATIONS | Search EXACERBATIONS |
| 4 | SPIROMETRY | 54 | 16% | 9% | 309 | Search SPIROMETRY | Search SPIROMETRY |
| 5 | EXACERBATION | 46 | 22% | 5% | 190 | Search EXACERBATION | Search EXACERBATION |
| 6 | LOWER LIMIT OF NORMAL | 14 | 59% | 0% | 16 | Search LOWER+LIMIT+OF+NORMAL | Search LOWER+LIMIT+OF+NORMAL |
| 7 | CHRONIC BRONCHITIS | 14 | 13% | 3% | 94 | Search CHRONIC+BRONCHITIS | Search CHRONIC+BRONCHITIS |
| 8 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD | 13 | 16% | 2% | 77 | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE+COPD | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE+COPD |
| 9 | FEV6 | 11 | 100% | 0% | 6 | Search FEV6 | Search FEV6 |
| 10 | AIRFLOW OBSTRUCTION | 8 | 21% | 1% | 35 | Search AIRFLOW+OBSTRUCTION | Search AIRFLOW+OBSTRUCTION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COPD | 155 | 15% | 27% | 970 |
| 2 | FLUTICASONE PROPIONATE SALMETEROL 250 50 | 80 | 90% | 1% | 35 |
| 3 | AIR FLOW OBSTRUCTION | 68 | 17% | 10% | 361 |
| 4 | SALMETEROL FLUTICASONE PROPIONATE | 66 | 51% | 3% | 91 |
| 5 | COPD EXACERBATIONS | 62 | 47% | 3% | 97 |
| 6 | COPD PREVALENCE | 57 | 95% | 1% | 19 |
| 7 | OFFICE SPIROMETRY | 54 | 73% | 1% | 41 |
| 8 | CHRONIC BRONCHITIS | 45 | 13% | 9% | 328 |
| 9 | FLUTICASONE PROPIONATE | 45 | 14% | 8% | 290 |
| 10 | SPIROMETRY | 43 | 19% | 6% | 200 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 75 | 34% | 5% | 183 |
| 2 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 43 | 27% | 4% | 134 |
| 3 | PRIMARY CARE RESPIRATORY JOURNAL | 23 | 28% | 2% | 68 |
| 4 | NPJ PRIMARY CARE RESPIRATORY MEDICINE | 10 | 32% | 1% | 27 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges | 2015 | 5 | 35 | 97% |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary | 2007 | 2474 | 209 | 28% |
| Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines | 2015 | 5 | 112 | 50% |
| Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management | 2015 | 3 | 65 | 65% |
| Global burden of COPD: risk factors, prevalence, and future trends | 2007 | 593 | 61 | 67% |
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | 2004 | 1760 | 83 | 22% |
| COPD: early diagnosis and treatment to slow disease progression | 2015 | 2 | 61 | 57% |
| Managing comorbidities in COPD | 2015 | 3 | 144 | 40% |
| Chronic obstructive pulmonary disease in non-smokers | 2009 | 263 | 69 | 38% |
| Global burden of COPD: systematic review and meta-analysis | 2006 | 429 | 60 | 55% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROGRAM EPIDEMIOL CLIN | 14 | 64% | 0.4% | 14 |
| 2 | CATEDRA UAM LINDE | 11 | 100% | 0.2% | 6 |
| 3 | CIBER ENFERMEDADES P CIBE | 10 | 23% | 1.1% | 39 |
| 4 | P ALLERGY GRP | 9 | 59% | 0.3% | 10 |
| 5 | PROGRAMA EPIDEMIOL INVEST CLIN | 8 | 75% | 0.2% | 6 |
| 6 | P SECT | 7 | 32% | 0.5% | 18 |
| 7 | CIMERA | 6 | 80% | 0.1% | 4 |
| 8 | CARDIOL P MED | 6 | 26% | 0.6% | 21 |
| 9 | FISIB | 6 | 42% | 0.3% | 11 |
| 10 | UNIT P MED | 6 | 16% | 0.9% | 33 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000218380 | CNR AGING BRANCH//CHRONIC OBSTRUCTIVE PULMONARY DISEASE CORTICOSTEROIDS//OPG RANK RANKL |
| 2 | 0.0000216297 | PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS |
| 3 | 0.0000212094 | TIOTROPIUM//INDACATEROL//LONG ACTING MUSCARINIC ANTAGONIST |
| 4 | 0.0000170228 | PULMONARY REHABILITATION//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//COPD |
| 5 | 0.0000150834 | SPIROMETRY//PEAK FLOW METERS//REFERENCE EQUATIONS |
| 6 | 0.0000117674 | BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE |
| 7 | 0.0000116469 | HLTH MED LIFE SCI C HRI//CIRO//ERSTA SKONDAL UNIV |
| 8 | 0.0000102565 | CIGARETTE SMOKE//EMPHYSEMA//LUNG BIOL DIS PROGRAM |
| 9 | 0.0000097720 | COPD RELATED PHENOTYPES//IREB2//FAM13A |
| 10 | 0.0000097275 | AGEING LUNG//SELF REPORTED ASTHMA//CATTEDRA MALATTIE P |